Literature DB >> 32868344

Cigarette Smoke Exposure Promotes Virulence of Pseudomonas aeruginosa and Induces Resistance to Neutrophil Killing.

Jason Chien1,2, John H Hwang1,2, Sedtavut Nilaad1,2, Jorge A Masso-Silva1,2, Sae Jeong Ahn1,2, Elisa K McEachern1,2, Alexander Moshensky1,2, Min-Kwang Byun1,2,3, Laura E Crotty Alexander4,2.   

Abstract

It is widely known that cigarette smoke damages host defenses and increases susceptibility to bacterial infections. Pseudomonas aeruginosa, a Gram-negative bacterium that commonly colonizes the airways of smokers and patients with chronic lung disease, can cause pneumonia and sepsis and can trigger exacerbations of lung diseases. Pseudomonas aeruginosa colonizing airways is consistently exposed to inhaled cigarette smoke. Here, we investigated whether cigarette smoke alters the ability of this clinically significant microbe to bypass host defenses and cause invasive disease. We found that cigarette smoke extract (CSE) exposure enhances resistance to human neutrophil killing, but this increase in pathogenicity was not due to resistance to neutrophil extracellular traps. Instead, Pseudomonas aeruginosa exposed to CSE (CSE-PSA) had increased resistance to oxidative stress, which correlated with increased expression of tpx, a gene essential for defense against oxidative stress. In addition, exposure to CSE induced enhanced biofilm formation and resistance to the antibiotic levofloxacin. Finally, CSE-PSA had increased virulence in a model of pneumonia, with 0% of mice infected with CSE-PSA alive at day 6, while 28% of controls survived. Altogether, these data show that cigarette smoke alters the phenotype of P. aeruginosa, increasing virulence and making it less susceptible to killing by neutrophils and more capable of causing invasive disease. These findings provide further explanation of the refractory nature of respiratory illnesses in smokers and highlight cigarette smoking as a potential driver of virulence in this important airway pathogen.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Pseudomonas aeruginosazzm321990; bacterial virulence; biofilm; cigarette smoke; neutrophil; oxidative burst; pneumonia

Mesh:

Substances:

Year:  2020        PMID: 32868344      PMCID: PMC7573448          DOI: 10.1128/IAI.00527-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  58 in total

1.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

Authors:  J Angrill; C Agustí; R de Celis; A Rañó; J Gonzalez; T Solé; A Xaubet; R Rodriguez-Roisin; A Torres
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

2.  Molecular basis of tobacco-induced bacterial biofilms: an in vitro study.

Authors:  Marcelo B Antunes; John J Chi; Zhi Liu; Natalia Goldstein-Daruech; James N Palmer; Jun Zhu; Noam A Cohen
Journal:  Otolaryngol Head Neck Surg       Date:  2012-05-17       Impact factor: 3.497

3.  Effects of cigarette smoking intensity on the mucociliary clearance of active smokers.

Authors:  Rafaella Fagundes Xavier; Dionei Ramos; Juliana Tiyaki Ito; Fernanda Maria Machado Rodrigues; Giovana Navarro Bertolini; Mariangela Macchione; Alessandra Choqueta de Toledo; Ercy Mara Cipulo Ramos
Journal:  Respiration       Date:  2013-04-19       Impact factor: 3.580

4.  Pseudomonas aeruginosa thiol peroxidase protects against hydrogen peroxide toxicity and displays atypical patterns of gene regulation.

Authors:  Nawarat Somprasong; Thichakorn Jittawuttipoka; Jintana Duang-Nkern; Adisak Romsang; Pimchai Chaiyen; Herbert P Schweizer; Paiboon Vattanaviboon; Skorn Mongkolsuk
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

5.  Cigarette smoke increases Staphylococcus aureus biofilm formation via oxidative stress.

Authors:  Ritwij Kulkarni; Swati Antala; Alice Wang; Fábio E Amaral; Ryan Rampersaud; Samuel J Larussa; Paul J Planet; Adam J Ratner
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

6.  Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.

Authors:  R Srikumar; T Kon; N Gotoh; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

7.  Streptococcus pneumoniae adherence in rats under different degrees and durations of cigarette smoke.

Authors:  Tevfik Ozlu; Ilknur Celik; Funda Oztuna; Yilmaz Bulbul; Savas Ozsu
Journal:  Respiration       Date:  2007-12-10       Impact factor: 3.580

8.  Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa.

Authors:  X Z Li; H Nikaido; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 9.  Neutrophils and Immunity: From Bactericidal Action to Being Conquered.

Authors:  Tie-Shan Teng; Ai-Ling Ji; Xin-Ying Ji; Yan-Zhang Li
Journal:  J Immunol Res       Date:  2017-02-19       Impact factor: 4.818

10.  The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models.

Authors:  Gerrit John; Katrin Kohse; Jürgen Orasche; Ahmed Reda; Jürgen Schnelle-Kreis; Ralf Zimmermann; Otmar Schmid; Oliver Eickelberg; Ali Önder Yildirim
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

View more
  3 in total

Review 1.  Smoking-induced microbial dysbiosis in health and disease.

Authors:  Hagit Shapiro; Kim Goldenberg; Karina Ratiner; Eran Elinav
Journal:  Clin Sci (Lond)       Date:  2022-09-30       Impact factor: 6.876

Review 2.  A Systematic Review of the Literature Examining the Effects of Cigarette Smoke and e-Cigarette Vapor on the Virulence of Human Pathogenic Bacteria.

Authors:  Kamal Bagale; Ritwij Kulkarni
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

3.  Transcriptional Response of Mycobacterium tuberculosis to Cigarette Smoke Condensate.

Authors:  Danicke Willemse; Chivonne Moodley; Smriti Mehra; Deepak Kaushal
Journal:  Front Microbiol       Date:  2021-10-15       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.